CAS: 71643-66-8; 4-Chloro-2-Iodophenol

相似化合物

15459-50-4 28177-52-8 2040-83-7

上下游产品

2-Iodophenol 4-chloro-phenol 2-hydroxy-5-chloro-aniline 4-chloro-2-iodo-1-methoxybenzene 2,4-dichloro-6-iodophenol 4-chloro-2,6-diiodo-phenol 4-chloro-2-iodophenyl acetate

4-氯-2-碘苯甲醚,在 三溴化硼,甲醇体系中,化学反应 3.5H,以88%的收率获得产物4-氯-2-碘苯酚
参考文献:Fused Tricyclic Compounds As Inhibitors Of 17Beta-Hydroxysteroid Dehydrogenase 3
标题:Fused Tricyclic Compounds As Inhibitors Of 17Beta-Hydroxysteroid Dehydrogenase 3
摘要:融合三环化合物,使用这种化合物治疗激素敏感性疾病如前列腺癌的方法,以及含有这种化合物的药物组合物.

专利信息

专利号:EP-1491540-B1
优先权日:2001-03-30
标题 :Intermediates useful for the synthesis of pyridazinone aldose reductase inhibitors

专利号:US-7473786-B1
优先权日:2003-12-05
标题:Methods and systems for preparing fused heterocyclic compounds using copper(I) catalysts
发明人：VENKATARAMAN DHANDAPANI; BATES CRAIG G; SAEJUENG PRANORM
权利人:UNIV MASSACHUSETTS
摘要:A copper(I)-catalyzed procedure for the synthesis of benzo[b]heterocycles. This protocol can be used to synthesize a variety of 2-arylbenzo[b]furans and indoles in good to excellent yields. This method can tolerate a variety of functional groups, does not require the use of expensive additives and is palladium-free.

专利号:ES-2274369-T3
优先权日:2001-03-30
标 题:USEFUL INTERMEDIATES FOR SYNTHESIS OF PIRIDAZINONAS INHIBIDORAS OF ALDOSA REDUCTASA.

专利号:US-9067934-B2
优先权日:2011-03-31
标题 :Bicyclic pyridinones
发明人：PETTERSSON MARTIN YOUNGJIN; JOHNSON DOUGLAS SCOTT; SUBRAMANYAM CHAKRAPANI; O'DONNELL CHRISTOPHER JOHN; AM ENDE CHRISTOPHER WILLIAM; FISH BENJAMIN ADAM; GREEN MICHAEL ERIC; MULLINS PATRICK BRADLEY; STIFF CORY MICHAEL; TRAN TUAN PHONG; NAVARATNAM THAYALAN
权利人:PFIZER
摘要:Compounds and pharmaceutically acceptable salts of the compounds are disclosed, wherein the compounds have the structure of Formula I n nas defined herein. Corresponding pharmaceutical compositions, methods of treatment, methods of synthesis, and intermediates are also disclosed.

专利号:CN-115197182-A
优先权日:2022-07-01
标 题:A kind of synthesis technique of halogenated dibenzofuran derivative

专利号:US-11286268-B1
优先权日:2019-07-02
标题:EIF4E-inhibiting compounds and methods
发明人：SPERRY SAMUEL; XIANG ALAN X; ERNST JUSTIN T; REICH SIEGFRIED H; SPRENGELER PAUL A; SHAGHAFI MIKE; MICHELS THEO; NILEWSKI CHRISTIAN; TRAN CHINH VIET; PACKARD Garrick Kenneth; GRUBBS ALAN; URKALAN KAVERI; MUKAIYAMA TAKASUKE
权利人:EFFECTOR THERAPEUTICS INC
摘要:The present invention provides synthesis, pharmaceutically acceptable formulations and uses of compounds in accordance with Formula I, or a stereoisomer, tautomer or pharmaceutically acceptable salt thereof. n n n n n n n n n n For Formula I compounds X 1 , X 2 , X 3 , X 4 , X 5 , X 6 , Q, L 1 , L 2 , Y, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 and rings A, B and C are as defined in the specification. The inventive Formula I compounds are inhibitors of eIF4e and find utility in any number of therapeutic applications, including but not limited to treatment of inflammation and various cancers.